{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:40:43Z","timestamp":1785897643492,"version":"3.56.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["anesthesiology.theclinics.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anesthesiology Clinics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.anclin.2025.07.004","type":"journal-article","created":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T05:01:38Z","timestamp":1757826098000},"page":"645-658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Perioperative Considerations for Medications for Opioid Use Disorder"],"prefix":"10.1016","volume":"43","author":[{"given":"T. Kyle","family":"Harrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Kornfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj Kailash","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.anclin.2025.07.004_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: population estimates - United States, 2022","volume":"73","author":"Dowell","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.anclin.2025.07.004_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229174","article-title":"National U.S. time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality","volume":"15","author":"Singh","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.anclin.2025.07.004_bib3","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.anclin.2025.07.004_bib4","doi-asserted-by":"crossref","DOI":"10.52965\/001c.37517","article-title":"Buprenorphine and its formulations: a comprehensive review","volume":"10","author":"Poliwoda","year":"2022","journal-title":"Health Psychol Res"},{"key":"10.1016\/j.anclin.2025.07.004_bib5","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone","volume":"41","author":"Eap","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.anclin.2025.07.004_bib6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.anclin.2018.04.002","article-title":"Perioperative considerations for the patient with opioid use disorder on buprenorphine, methadone, or naltrexone maintenance therapy","volume":"36","author":"Harrison","year":"2018","journal-title":"Anesthesiol Clin"},{"key":"10.1016\/j.anclin.2025.07.004_bib7","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0022-3565(24)39007-X","article-title":"Opioid receptor imaging with positron emission tomography and [(18)F]cyclofoxy in long-term, methadone-treated former heroin addicts","volume":"295","author":"Kling","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.anclin.2025.07.004_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","article-title":"Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review","volume":"19","author":"McCance-Katz","year":"2010","journal-title":"Am J Addict"},{"issue":"2","key":"10.1016\/j.anclin.2025.07.004_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1213\/ANE.0000000000005366","article-title":"A novel perioperative multidose methadone-based multimodal analgesic strategy in children achieved safe and low analgesic Blood methadone levels enabling opioid-sparing sustained analgesia with minimal adverse effects","volume":"133","author":"Sadhasivam","year":"2021","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.anclin.2025.07.004_bib10","article-title":"Methadone maintenance at different dosages for opioid dependence","volume":"2010","author":"Faggiano","year":"1996","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.anclin.2025.07.004_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/10550887.2011.610710","article-title":"QT interval screening in methadone maintenance treatment: report of a SAMHSA expert panel","volume":"30","author":"Martin","year":"2011","journal-title":"J Addict Dis"},{"key":"10.1016\/j.anclin.2025.07.004_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/BF03016532","article-title":"Perioperative pain management of patients on methadone therapy","volume":"52","author":"Peng","year":"2005","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.anclin.2025.07.004_bib13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jpainsymman.2004.07.005","article-title":"Buprenorphine: considerations for pain management","volume":"29","author":"Johnson","year":"2005","journal-title":"J Pain Symptom Manage"},{"issue":"4","key":"10.1016\/j.anclin.2025.07.004_bib14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/pm\/pnz356","article-title":"Understanding buprenorphine for use in chronic pain: expert opinion","volume":"21","author":"Webster","year":"2020","journal-title":"Pain Med"},{"key":"10.1016\/j.anclin.2025.07.004_bib15","series-title":"Orange book: approved drug products with therapeutic equivalence evaluations","year":"2017"},{"issue":"3 Suppl","key":"10.1016\/j.anclin.2025.07.004_bib16","doi-asserted-by":"crossref","first-page":"ES59","DOI":"10.36076\/ppj.2012\/15\/ES59","article-title":"Conversion of chronic pain patients from full-opioid agonists to sublingual buprenorphine","volume":"15","author":"Daitch","year":"2012","journal-title":"Pain Physician"},{"issue":"16","key":"10.1016\/j.anclin.2025.07.004_bib17","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1056\/NEJMc2312906","article-title":"Buprenorphine dispensing after elimination of the waiver requirement","volume":"390","author":"Chua","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.anclin.2025.07.004_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/jcpt.12196","article-title":"The clinical analgesic efficacy of buprenorphine","volume":"39","author":"Raffa","year":"2014","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.anclin.2025.07.004_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2217\/pmt-2018-0069","article-title":"Recommending buprenorphine for pain management","volume":"9","author":"Ehrlich","year":"2019","journal-title":"Pain Manag"},{"issue":"2","key":"10.1016\/j.anclin.2025.07.004_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pmr.2020.02.001","article-title":"Buprenorphine in the treatment of chronic pain","volume":"31","author":"Rudolf","year":"2020","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1016\/j.anclin.2025.07.004_bib21","series-title":"Buprenorphine- the unique opioid analgesic","first-page":"22","article-title":"New insights into buprenorphine\u2019s respiratory effects","author":"Dahan","year":"2005"},{"key":"10.1016\/j.anclin.2025.07.004_bib22","series-title":"Handbook of methadone prescribing and buprenorphine therapy","first-page":"163","article-title":"Buprenorphine pharmacodynamics and pharmacokinetics","author":"Walsh","year":"2013"},{"issue":"10","key":"10.1016\/j.anclin.2025.07.004_bib23","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/rapm-2021-103092","article-title":"Guidelines for the use of buprenorphine for opioid use disorder in the perioperative setting","volume":"46","author":"Kohan","year":"2021","journal-title":"Reg Anesth Pain Med"},{"issue":"51","key":"10.1016\/j.anclin.2025.07.004_bib24","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032309","article-title":"A prospective, randomized trial of the effect of buprenorphine continuation versus dose reduction on pain control and post-operative opioid use","volume":"101","author":"Quaye","year":"2022","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.anclin.2025.07.004_bib25","series-title":"\u201cThe efficacy in sequential use of buprenorphine and morphine in advanced cancer pain\u201d. Opioids in the treatment of cancer pain","author":"Atkinson","year":"1990"},{"key":"10.1016\/j.anclin.2025.07.004_bib26","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.npp.1300251","article-title":"Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers","volume":"28","author":"Greenwald","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.anclin.2025.07.004_bib27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MJT.0b013e3181be0804","article-title":"Effectiveness of full agonist opioids in patients stabilized on buprenorphine undergoing major surgery: a case series","volume":"17","author":"Kornfeld","year":"2010","journal-title":"Am J Ther"},{"key":"10.1016\/j.anclin.2025.07.004_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jss.2023.03.021","article-title":"Acute pain management in traumatically injured patients with outpatient buprenorphine therapy","volume":"289","author":"Culshaw","year":"2023","journal-title":"J Surg Res"},{"issue":"24","key":"10.1016\/j.anclin.2025.07.004_bib29","first-page":"00652","article-title":"Optimizing safe opioid prescribing: a paradigm shift in buprenorphine management for orthopaedic surgery","volume":"S0883-5403","author":"Morrissey","year":"2024","journal-title":"J Arthroplast"},{"issue":"3","key":"10.1016\/j.anclin.2025.07.004_bib30","doi-asserted-by":"crossref","first-page":"e404","DOI":"10.1016\/j.bja.2022.11.013","article-title":"Buprenorphine for chronic pain treatment and elective orthopaedic surgery: a US national database analysis","volume":"130","author":"Stone","year":"2023","journal-title":"Br J Anaesth"},{"issue":"9","key":"10.1016\/j.anclin.2025.07.004_bib31","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1053\/j.jvca.2022.04.050","article-title":"Buprenorphine and cardiac surgery: navigating the challenges of pain management","volume":"36","author":"Fernando","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.anclin.2025.07.004_bib32","article-title":"Peripartum and postpartum analgesia and pain in women prescribed buprenorphine for opioid use disorder who deliver by cesarean section","volume":"16","author":"O'Connor","year":"2022","journal-title":"Subst Abuse"},{"issue":"4","key":"10.1016\/j.anclin.2025.07.004_bib33","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/ajad.13396","article-title":"Patients\u2019 experiences with continuation or discontinuation of buprenorphine before painful procedures: a brief report","volume":"32","author":"Hathaway","year":"2023","journal-title":"Am J Addict"},{"key":"10.1016\/j.anclin.2025.07.004_bib34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jss.2024.06.024","article-title":"Perioperative management of buprenorphine at an urban academic medical center","volume":"302","author":"Brighton","year":"2024","journal-title":"J Surg Res"},{"issue":"10","key":"10.1016\/j.anclin.2025.07.004_bib35","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1111\/add.16223","article-title":"Postoperative buprenorphine continuation in stabilized buprenorphine patients: a population cohort study","volume":"118","author":"Hauck","year":"2023","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.anclin.2025.07.004_bib36","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/ADM.0000000000001191","article-title":"Current state of perioperative buprenorphine management-A national provider Survey","volume":"17","author":"Quaye","year":"2023","journal-title":"J Addict Med"},{"issue":"1","key":"10.1016\/j.anclin.2025.07.004_bib37","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1097\/ADM.0000000000001024","article-title":"Perioperative management of extended-release buprenorphine","volume":"17","author":"Hickey","year":"2023","journal-title":"J Addict Med"},{"issue":"1","key":"10.1016\/j.anclin.2025.07.004_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/08897077231167043","article-title":"Perioperative management of extended-release buprenorphine: a narrative review and case series","volume":"44","author":"Hickey","year":"2023","journal-title":"Subst Abus"},{"issue":"6","key":"10.1016\/j.anclin.2025.07.004_bib39","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/ALN.0000000000001633","article-title":"To stop or not, that is the question-acute pain management for the patient on chronic buprenorphine","volume":"126","author":"Anderson","year":"2017","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1016\/j.anclin.2025.07.004_bib40","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1089\/jpm.2012.9591","article-title":"Treatment of pain in patients taking buprenorphine for opioid addiction #221","volume":"15","author":"Childers","year":"2012","journal-title":"J Palliat Med"},{"key":"10.1016\/j.anclin.2025.07.004_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.16118","article-title":"A retrospective analysis of perioperative medications for opioid-use disorder and tapering additional postsurgical opioids via a transitional pain service","author":"Liu","year":"2024","journal-title":"Br J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.anclin.2025.07.004_bib42","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.bmcl.2009.02.078","article-title":"Syntheses of novel high affinity ligands for opioid receptors","volume":"19","author":"Wentland","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.anclin.2025.07.004_bib43","first-page":"105","article-title":"The metabolism of naltrexone in man","volume":"28","author":"Wall","year":"1981","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.anclin.2025.07.004_bib44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13181-015-0512-x","article-title":"Naltrexone: not just for opioids anymore","volume":"12","author":"Sudakin","year":"2016","journal-title":"J Med Toxicol"},{"issue":"2","key":"10.1016\/j.anclin.2025.07.004_bib45","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/ALN.0000000000005040","article-title":"Perioperative naltrexone management: a scoping review by the perioperative pain and addiction interdisciplinary network","volume":"141","author":"Goel","year":"2024","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.anclin.2025.07.004_bib46","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1530-0277.2006.00052.x","article-title":"Single- and multiple-dose pharmacokinetics of long acting injectable naltrexone","volume":"30","author":"Dunbar","year":"2006","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.anclin.2025.07.004_bib47","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1213\/XAA.0000000000000069","article-title":"Challenges in the perioperative management of the patient receiving extended-release naltrexone","volume":"3","author":"Curatolo","year":"2014","journal-title":"A A Case Reports"},{"key":"10.1016\/j.anclin.2025.07.004_bib48","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.pbb.2008.02.006","article-title":"Overriding the blockade of antinociceptive actions of opioids in rats treated with extended-release naltrexone","volume":"89","author":"Dean","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.anclin.2025.07.004_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0306-4522(02)00073-8","article-title":"Regulation of mu-opioid receptors, G-protein-coupled receptor kinases and beta-arrestin 2 in the rat brain after chronic opioid receptor antagonism","volume":"112","author":"D\u00edaz","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.anclin.2025.07.004_bib50","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0022-3565(25)20595-X","article-title":"Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation","volume":"232","author":"Tempel","year":"1985","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.anclin.2025.07.004_bib51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/00952990.2011.653426","article-title":"Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice","volume":"38","author":"Sigmon","year":"2012","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"9","key":"10.1016\/j.anclin.2025.07.004_bib52","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/jhm.12893","article-title":"Management of opioid use disorder and associated conditions among hospitalized adults: a Consensus Statement from the Society of Hospital Medicine","volume":"17","author":"Calcaterra","year":"2022","journal-title":"J Hosp Med"},{"key":"10.1016\/j.anclin.2025.07.004_bib53","unstructured":"Available at: https:\/\/www.federalregister.gov\/documents\/2024\/02\/02\/2024-01693\/medications-for-the-treatment-of-opioid-use-disorder. Accessed 27 August 2025."},{"issue":"2","key":"10.1016\/j.anclin.2025.07.004_bib54","article-title":"Managing opioid use disorder during and after acute hospitalization: a case-based review clarifying methadone regulation for acute care settings","volume":"4","author":"Noska","year":"2015","journal-title":"J Addict Behav Ther Rehabil"},{"issue":"1","key":"10.1016\/j.anclin.2025.07.004_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1001\/jamainternmed.2019.5731","article-title":"Facilitating methadone use in hospitals and skilled nursing facilities","volume":"180","author":"Pytell","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.anclin.2025.07.004_bib56","unstructured":"U.S. Drug enforcement administration office of diversion control. Title 21, code of federal regulations 1306.07. Administering or dispensing of narcotic drugs, Available at: https:\/\/www.deadiversion.usdoj.gov\/drugreg\/Instructions-to-request-exception-to-21-CFR-1306.07(b)-3-day-rule-(EODEA248R1).pdf. Accessed: 27 August 2025."},{"key":"10.1016\/j.anclin.2025.07.004_bib57","unstructured":"Available at: https:\/\/www.samhsa.gov\/substanceuse\/treatment\/opioid-treatment-program\/42-cfr-part-8. Accessed: 27 August 2025"},{"key":"10.1016\/j.anclin.2025.07.004_bib58","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2215-0366(15)00366-1","article-title":"Mortality risk of opioid substitution therapy with methadone versus buprenorphine: A retrospective cohort study","volume":"2","author":"Kimber","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.anclin.2025.07.004_bib59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yrtph.2010.12.007","article-title":"Uniform assessment and ranking of opioid mu receptor binding constants for selected opioid drugs","volume":"59","author":"Volpe","year":"2011","journal-title":"Regul Toxicol Pharmacol"},{"issue":"4","key":"10.1016\/j.anclin.2025.07.004_bib60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/ADM.0000000000000947","article-title":"Low dose buprenorphine induction with full agonist overlap in hospitalized patients with opioid use disorder: a retrospective cohort study","volume":"16","author":"Bhatraju","year":"2022","journal-title":"J Addict Med"},{"issue":"1","key":"10.1016\/j.anclin.2025.07.004_bib61","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13722-023-00392-z","article-title":"Low dose IV buprenorphine inductions for patients with opioid use disorder and concurrent pain: a retrospective case series","volume":"18","author":"Murray","year":"2023","journal-title":"Addict Sci Clin Pract"},{"issue":"7","key":"10.1016\/j.anclin.2025.07.004_bib62","article-title":"Extended-release 7-day injectable buprenorphine for patients with minimal to mild opioid withdrawal","volume":"7","author":"D'Onofrio","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.anclin.2025.07.004_bib63","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/phar.2676","article-title":"Buprenorphine initiation strategies for opioid use disorder and pain management: a systematic review","volume":"42","author":"Spreen","year":"2022","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.anclin.2025.07.004_bib64","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-024-01276-w","article-title":"Adjuvant analgesics in acute pain - evaluation of efficacy","author":"Kummer","year":"2024","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.anclin.2025.07.004_bib65","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.anclin.2016.01.005","article-title":"Managing opioid-tolerant patients in the perioperative surgical home","volume":"34","author":"Wenzel","year":"2016","journal-title":"Anesthesiol Clin"}],"container-title":["Anesthesiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193222752500059X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193222752500059X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T15:09:44Z","timestamp":1766156984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193222752500059X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S193222752500059X"],"URL":"https:\/\/doi.org\/10.1016\/j.anclin.2025.07.004","relation":{},"ISSN":["1932-2275"],"issn-type":[{"value":"1932-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perioperative Considerations for Medications for Opioid Use Disorder","name":"articletitle","label":"Article Title"},{"value":"Anesthesiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anclin.2025.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}